- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Cosmo Pharmaceuticals to Host Full Year 2025 Financial Results Webcast
The company will present an in-depth overview of its latest financial and operational performance on March 9, 2026.
Jan. 28, 2026 at 12:47am
Got story updates? Submit your updates here. ›
Cosmo Pharmaceuticals N.V., a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing, announced that it will publish its Full-Year 2025 results on Monday, March 9, 2026 at 7:00 am CET. The company will host a live webcast presentation at 10:00 am CET the same day, where CEO Giovanni Di Napoli and CFO Svetlana Sigalova will discuss the company's financial and operational performance, strategic initiatives, growth opportunities, and outlook.
Why it matters
As a leading player in the life sciences industry, Cosmo's financial results and strategic direction are closely watched by investors, analysts, and industry stakeholders. The webcast presentation will provide valuable insights into the company's performance and future plans, which can impact its stock price and market position.
The details
Cosmo will publish its Full-Year 2025 results on March 9, 2026 and host a live webcast presentation at 10:00 am CET the same day. During the webcast, CEO Giovanni Di Napoli and CFO Svetlana Sigalova will discuss the company's latest financial and operational performance, strategic initiatives, growth opportunities, and outlook. A Q&A session will follow, allowing stakeholders to engage directly with the leadership team.
- Cosmo will publish its Full-Year 2025 results on Monday, March 9, 2026 at 7:00 am CET.
- The live webcast presentation will take place on March 9, 2026 at 10:00 am CET.
The players
Giovanni Di Napoli
Chief Executive Officer of Cosmo Pharmaceuticals N.V.
Svetlana Sigalova
Chief Financial Officer of Cosmo Pharmaceuticals N.V.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident (San Francisco Chronicle)
“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”
— Gordon Edgar, grocery employee (Instagram)
What’s next
The 2025 Annual Report and ESG Report will be available for download on March 9, 2026 as of 7:00 am CET at www.cosmohealthconfidence.com.
The takeaway
Cosmo's upcoming webcast presentation will provide investors, analysts, and industry stakeholders with valuable insights into the company's financial performance, strategic initiatives, and future outlook, which can impact its market position and stock price.
San Diego top stories
San Diego events
Mar. 18, 2026
Machine Girl - PsychoWarrior TourMar. 18, 2026
Four Stroke Baron & Cyborg Octopus with special guestsMar. 18, 2026
Sessa




